Last reviewed · How we verify
Fecundin (androstenedione)
Fecundin (generic name: androstenedione) is a androstenedione drug. It is currently in unknown development.
Fecundin works by binding to the aromatase enzyme and inhibiting its activity, which can lead to a decrease in estrogen production.
Fecundin, also known as androstenedione, is a small molecule drug that targets aromatase. It is classified as an androstenedione, but its commercial status and approved indications are unknown. As a small molecule, it is designed to interact with the aromatase enzyme, which is involved in the production of estrogen. The exact mechanism of action and safety considerations of Fecundin are unclear due to a lack of publicly available information. Further research is needed to fully understand its potential therapeutic applications and risks.
At a glance
| Generic name | androstenedione |
|---|---|
| Drug class | androstenedione |
| Target | Corticosteroid-binding globulin, Alpha-synuclein, Sex hormone-binding globulin |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Think of aromatase like a factory that produces estrogen. Fecundin is a key that blocks the factory's door, preventing estrogen from being made. This can be helpful in certain medical conditions, but it's a complex process that requires careful consideration.
Approved indications
Common side effects
Key clinical trials
- Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients
- A Deep Learning Method to Evaluate QT on Ribociclib
- Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1 (PHASE1)
- LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions
- Polycystic Ovary Syndrome and Urinary Tract Stones: a BMI-Adjusted Analysis in Iraqi Women
- Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer (PHASE2)
- The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris
- Evaluation of Serum Adrenal Androgens Among Prepubertal and Pubertal Boys With Autism Spectrum Disorder
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fecundin CI brief — competitive landscape report
- Fecundin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Fecundin
What is Fecundin?
How does Fecundin work?
What is the generic name of Fecundin?
What drug class is Fecundin in?
What development phase is Fecundin in?
What does Fecundin target?
Related
- Drug class: All androstenedione drugs
- Target: All drugs targeting Corticosteroid-binding globulin, Alpha-synuclein, Sex hormone-binding globulin
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing